Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

PET: brain tumor biochemistry

U Roelcke1

  • 1PET-Program, Paul Scherrer Institute, Villigen, Switzerland.

Journal of Neuro-Oncology
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Estimating brain tumor proliferation rates is crucial for effective chemotherapy. Positron emission tomography (PET) offers a way to measure this, guiding personalized treatment strategies for brain tumors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Next generation sequencing in adult patients with glioblastoma in Switzerland: a multi-centre decision analysis.

Journal of neuro-oncology·2022
Same author

Susceptibility and Tumor Size Changes During the Time Course of Standard Treatment in Recurrent Glioblastoma.

Journal of neuroimaging : official journal of the American Society of Neuroimaging·2019
Same author

Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: the randomized, open-label, phase II ARTE trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2018
Same author

Patterns of care in recurrent glioblastoma in Switzerland: a multicentre national approach based on diagnostic nodes.

Journal of neuro-oncology·2015
Same author

Susceptibility changes in meningiomas influence the apparent diffusion coefficient in diffusion-weighted MRI.

Journal of neuroradiology = Journal de neuroradiologie·2015
Same author

Alterations of cerebral metabolism or perfusion due to lesions of the central nervous system.

NeuroRehabilitation·2014

Area of Science:

  • Neuro-oncology
  • Medical imaging
  • Pharmacology

Background:

  • Chemotherapy drugs for brain tumors target specific cell cycle phases, particularly DNA synthesis.
  • Drug efficacy is linked to the proliferation rate of tumor cells.
  • Accurate assessment of tumor proliferation is vital for optimizing individual patient chemotherapy.

Purpose of the Study:

  • To review literature on Positron Emission Tomography (PET) tracers for assessing brain tumor proliferation.
  • To explore tracers reflecting tumor malignancy and those related to DNA synthesis.

Main Methods:

  • Literature review of PET imaging in brain tumors.
  • Analysis of tracer substances used to assess tumor malignancy (e.g., 11C-methionine, 18F-FDG).
  • Evaluation of tracers potentially reflecting DNA synthesis mechanisms (e.g., 11C-putrescine, peripheral benzodiazepine receptor ligands).

Related Experiment Videos

Main Results:

  • PET tracers like 11C-methionine and 18F-FDG have been investigated for reflecting tumor malignancy.
  • Specific tracers, including 11C-putrescine and ligands for peripheral benzodiazepine receptors, are theoretically linked to DNA synthesis.

Conclusions:

  • PET imaging holds promise for quantitatively assessing brain tumor proliferation in vivo.
  • Further research into specific PET tracers could enhance personalized chemotherapy for brain tumors.